Epidemiology of Type II Diabetes Thomas J. SongerPaul Z. Zimmet OriginalPaper 23 November 2012 Pages: 1 - 11
Type II Diabetes and Quality of Life Jan Olof HörnquistAnders WikbyIngemar Åkerlind OriginalPaper 23 November 2012 Pages: 12 - 16
Quality of Life in Type II Diabetes Christine EiserJohn E. Tooke OriginalPaper 23 November 2012 Pages: 17 - 22
The Indirect Costs of Morbidity in Type II Diabetic Patients Ulf Persson OriginalPaper 23 November 2012 Pages: 28 - 32
Cost Savings Associated with Detection and Treatment of Diabetic Eye Disease Jonathan C. Javitt OriginalPaper 23 November 2012 Pages: 33 - 39
The Costs of Nephropathy in Type II Diabetes Knut Barch-Johnsen OriginalPaper 23 November 2012 Pages: 40 - 45
Direct and Indirect Costs of Cardiovascular and Cerebrovascular Complications of Type II Diabetes Kenneth M. MacLeodJohn E. Tooke OriginalPaper 23 November 2012 Pages: 46 - 51
Evaluative Approaches to Type II Diabetes Annie Triomphe OriginalPaper 23 November 2012 Pages: 58 - 61
Global Healthcare Financing for Type II Diabetes Thomas D. Szucs OriginalPaper 23 November 2012 Pages: 62 - 67
Cost-Effectiveness of Diabetes Education Jean-Philippe Assal OriginalPaper 23 November 2012 Pages: 68 - 71
Pharmacoeconomics of Diabetes Surveillance and Detection Programmes Philip D. Home OriginalPaper 23 November 2012 Pages: 72 - 79
Applying Recent Findings to Clinical Care in Type II Diabetes Rhys Williams OriginalPaper 23 November 2012 Pages: 80 - 84
